Researchers examine how the use of animal testing to identify endocrine-disrupting substances in the EU can be reduced.

Researchers examine how the use of animal testing to identify endocrine-disrupting substances in the EU can be reduced.

Merlon Capital Partners' Julian McCormack is not just bullish, he thinks they are both presenting a value opportunity. In fact, “this is the only time in 14 years we have owned both Coles and ...

Merlon Intelligence announces Stephen Epstein as Chief Innovation Officer and CB Insights names company to the AI 100 2018 list as an AI leader ...

A team from the MERLON research project, led by the DTU National Food Institute, has mapped the use of alternatives to animal testing – so-called New Approach Methodologies (NAMs) – in the ...